Day: April 7, 2025

European Commission approves subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer

Subcutaneous (SC) amivantamab offers patients greater convenience, reducing administration time from hours to minutes and with a five-fold reduction in...

Nelipak® Healthcare Packaging Expands Commitment to Serve Customers in Asia-Pacific Region with its Sterile Barrier Medical Packaging Products

Expanding Regional Expertise and Localized Solutions to Meet the Growing Demands of Asia-Pacific Healthcare.CRANSTON, R.I., April 07, 2025 (GLOBE NEWSWIRE)...

Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool

NEW YORK and WOONSOCKET, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of...

error: Content is protected !!